Constitutive Regulation of Cardiac Fatty Acid Metabolism through Peroxisome Proliferator-activated Receptor α Associated with Age-dependent Cardiac Toxicity
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
The peroxisome proliferator-activated receptor alpha (PPARalpha) is a member of the nuclear receptor superfamily and mediates the biological effects of peroxisome proliferators. To determine the physiological role of PPARalpha in cardiac fatty acid metabolism, we examined the regulation of expression of cardiac fatty acid-metabolizing proteins using PPARalpha-null mice. The capacity for constitutive myocardial beta-oxidation of the medium and long chain fatty acids, octanoic acid and palmitic acid, was markedly reduced in the PPARalpha-null mice as compared with the wild-type mice, indicating that mitochondrial fatty acid catabolism is impaired in the absence of PPARalpha. In contrast, constitutive beta-oxidation of the very long chain fatty acid, lignoceric acid, did not differ between the mice, suggesting that the constitutive expression of enzymes involved in peroxisomal beta-oxidation is independent of PPARalpha(.) Indeed, PPARalpha-null mice had normal levels of the peroxisomal beta-oxidation enzymes except the D-type bifunctional protein. At least seven mitochondrial fatty acid-metabolizing enzymes were expressed at much lower levels in the PPARalpha-null mice, whereas other fatty acid-metabolizing enzymes were present at similar or slightly lower levels in the PPARalpha-null, as compared with wild-type mice. Additionally, lower constitutive mRNA expression levels of fatty acid transporters were found in the PPARalpha-null mice, suggesting a role for PPARalpha in fatty acid transport and catabolism. Indeed, in fatty acid metabolism experiments in vivo, myocardial uptake of iodophenyl 9-methylpentadecanoic acid and its conversion to 3-methylnonanoic acid were reduced in the PPARalpha-null mice. Interestingly, a decreased ATP concentration after exposure to stress, abnormal cristae of the mitochondria, abnormal caveolae, and fibrosis were observed only in the myocardium of the PPARalpha-null mice. These cardiac abnormalities appeared to proceed in an age-dependent manner. Taken together, the results presented here indicate that PPARalpha controls constitutive fatty acid oxidation, thus establishing a role for the receptor in cardiac fatty acid homeostasis. Furthermore, altered expression of fatty acid-metabolizing proteins seems to lead to myocardial damage and fibrosis, as inflammation and abnormal cell growth control can cause these conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“cardiac specific knockout of PPARα causes deficiencies in mitochondrial β-oxidation, leading to eventual myocardial damage and fibrosis [113].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [113]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
Self-citationPeroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649
Self-citationThe PPARα–leukotriene B4 pathway to inflammation control
Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W. (1996) · Nature · doi:10.1038/384039a0 · Cited by 1,345
Self-citationActivation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
Staels, B., Koenig, W., Habib, A., Merval, R., Lebret, M., Torra, I. P., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J.-C., et al. (1998) · Nature · doi:10.1038/31701 · Cited by 1,134
Abumrad, N. A., el-Maghrabi, M. R., Amri, E. Z., Lopez, E., & Grimaldi, P. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46753-6 · Cited by 1,002
Leone, T. C., Weinheimer, C. J., & Kelly, D. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7473 · Cited by 943
Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein
Schaffer, J. E., & Lodish, H. F. (1994) · Cell · doi:10.1016/0092-8674(94)90252-6 · Cited by 872
Research works printed but not linked: 4
- 9. Chouraqui, P. ∙ Maddahi, J. ∙ Henkin, R. ... J. Nucl. Med. 1991; 32:447-452 PubMed Google Scholar
- Lefer, 1985, Fed. Proc., 44, 275
- Lefer, 1987, Arch. Int. Pharm. Ther., 287, 89
- Lefer, 1987, Cardiovasc. Clin., 18, 85
Cited by
Myocardial Fatty Acid Metabolism in Health and Disease
Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00015.2009 · Cited by 2,179
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., et al. (2002) · Nature Medicine · doi:10.1038/nm724 · Cited by 2,088
Self-citationPPAR control of metabolism and cardiovascular functions
Montaigne, D., Butruille, L., & Staels, B. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00569-6 · Cited by 942
Molecular Actions of PPARα in Lipid Metabolism and Inflammation
Bougarne, N., Weyers, B., Desmet, S. J., Deckers, J., Ray, D. W., Staels, B., & De Bosscher, K. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00064 · Cited by 898
Feige, J. N., Gelman, L., Michalik, L., Desvergne, B., & Wahli, W. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.12.002 · Cited by 786
The Biology of Peroxisome Proliferator-Activated Receptors
Ferré, P. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s43 · Cited by 776
Russell, R. R., Li, J., Coven, D. L., Pypaert, M., Zechner, C., Palmeri, M., Giordano, F. J., Mu, J., Birnbaum, M. J., & Young, L. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19297 · Cited by 738
Huynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 553
Mitochondrial energy metabolism in heart failure: a question of balance
Huss, J. M., & Kelly, D. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524405 · Cited by 533
PPAR Signaling in the Control of Cardiac Energy Metabolism
Barger, P. M., & Kelly, D. P. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(00)00077-3 · Cited by 506
Nuclear Receptor Signaling and Cardiac Energetics
Huss, J. M., & Kelly, D. P. (2004) · Circulation Research · doi:10.1161/01.res.0000141774.29937.e3 · Cited by 473
Mitochondrial biogenesis and dynamics in the developing and diseased heart
Dorn, G. W., Vega, R. B., & Kelly, D. P. (2015) · Genes & Development · doi:10.1101/gad.269894.115 · Cited by 470
Cheng, L., Ding, G., Qin, Q., Huang, Y., Lewis, W., He, N., Evans, R. M., Schneider, M. D., Brako, F. A., Xiao, Y., et al. (2004) · Nature Medicine · doi:10.1038/nm1116 · Cited by 453
“Notably, conventional Ppara knockout mice also show decreased expression of myocardial FAO gene”
BackgroundGilde, A. J., van der Lee, K. A. J. M., Willemsen, P. H. M., Chinetti, G., van der Leij, F. R., van der Vusse, G. J., Staels, B., & van Bilsen, M. (2003) · Circulation Research · doi:10.1161/01.res.0000060700.55247.7c · Cited by 399
Muoio, D. M., MacLean, P. S., Lang, D. B., Li, S., Houmard, J. A., Way, J. M., Winegar, D. A., Corton, J. C., Dohm, G. L., & Kraus, W. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203997200 · Cited by 398
Elrod, J. W., Wong, R., Mishra, S., Vagnozzi, R. J., Sakthievel, B., Goonasekera, S. A., Karch, J., Gabel, S., Farber, J., Force, T., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43171 · Cited by 384
Peroxisome Proliferator-Activated Receptors: Vascular and Cardiac Effects in Hypertension
Schiffrin, E. L., Amiri, F., Benkirane, K., Iglarz, M., & Diep, Q. N. (2003) · Hypertension · doi:10.1161/01.hyp.0000084370.74777.b6 · Cited by 369
Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice
Montgomery, R. L., Potthoff, M. J., Haberland, M., Qi, X., Matsuzaki, S., Humphries, K. M., Richardson, J. A., Bassel-Duby, R., & Olson, E. N. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35847 · Cited by 362
Osorio, J. C., Stanley, W. C., Linke, A., Castellari, M., Diep, Q. N., Panchal, A. R., Hintze, T. H., Lopaschuk, G. D., & Recchia, F. A. (2002) · Circulation · doi:10.1161/01.cir.0000023531.22727.c1 · Cited by 332
Fischer, M., You, M., Matsumoto, M., & Crabb, D. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302140200 · Cited by 291
p38 Mitogen-activated Protein Kinase Activates Peroxisome Proliferator-activated Receptor α
Barger, P. M., Browning, A. C., Garner, A. N., & Kelly, D. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105945200 · Cited by 260
Campbell, F. M., Kozak, R., Wagner, A., Altarejos, J. Y., Dyck, J. R. B., Belke, D. D., Severson, D. L., Kelly, D. P., & Lopaschuk, G. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106054200 · Cited by 260
Szczepaniak, L. S., Victor, R. G., Orci, L., & Unger, R. H. (2007) · Circulation Research · doi:10.1161/circresaha.107.160457 · Cited by 257
Zhang, L., Keung, W., Samokhvalov, V., Wang, W., & Lopaschuk, G. D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.014 · Cited by 257
The PPAR trio: Regulators of myocardial energy metabolism in health and disease
Madrazo, J. A., & Kelly, D. P. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.03.021 · Cited by 242
Statins: a new insight into their mechanisms of action and consequent pleiotropic effects.
Jasińska-Stroschein, M., Owczarek, J., & Orszulak–Michalak, D. (2007) · PubMed · Cited by 235
The PPAR regulatory system in cardiac physiology and disease
FINCK, B. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.08.023 · Cited by 223
Sundström, J., Bruze, G., Ottosson, J., Marcus, C., Näslund, I., & Neovius, M. (2017) · Circulation · doi:10.1161/circulationaha.116.025629 · Cited by 214
Peroxisome proliferator-activated receptor ? protects against alcohol-induced liver damage
Nakajima, T., Kamijo, Y., Tanaka, N., Sugiyama, E., Tanaka, E., Kiyosawa, K., Fukushima, Y., Peters, J. M., Gonzalez, F. J., & Aoyama, T. (2004) · Hepatology · doi:10.1002/hep.20399 · Cited by 214
Self-citationPPARs and the Cardiovascular System
Hamblin, M., Chang, L., Fan, Y., Zhang, J., & Chen, Y. E. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2280 · Cited by 207
Epigenetics and Cardiovascular Development
Chang, C.-P., & Bruneau, B. G. (2012) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020911-153242 · Cited by 202
Yue, T.-L., Bao, W., Jucker, B. M., Gu, J.-L., Romanic, A. M., Brown, P. J., Cui, J., Thudium, D. T., Boyce, R., Burns-Kurtis, C. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000093187.42015.6c · Cited by 189
Gilde, A. J., & Van Bilsen, M. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01161.x · Cited by 178
Luptak, I., Balschi, J. A., Xing, Y., Leone, T. C., Kelly, D. P., & Tian, R. (2005) · Circulation · doi:10.1161/circulationaha.105.534594 · Cited by 175
Aging-induced decrease in the PPAR-α level in hearts is improved by exercise training
Iemitsu, M., Miyauchi, T., Maeda, S., Tanabe, T., Takanashi, M., Irukayama-Tomobe, Y., Sakai, S., Ohmori, H., Matsuda, M., & Yamaguchi, I. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01051.2001 · Cited by 166
Ogata, T., Miyauchi, T., Sakai, S., Takanashi, M., Irukayama-Tomobe, Y., & Yamaguchi, I. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.11.043 · Cited by 165
PGC-1α in aging and anti-aging interventions
Anderson, R., & Prolla, T. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.04.005 · Cited by 162
Jamshidi, Y., Montgomery, H. E., Hense, H.-W., Myerson, S. G., Torra, I. P., Staels, B., World, M. J., Doering, A., Erdmann, J., Hengstenberg, C., et al. (2002) · Circulation · doi:10.1161/hc0802.104535 · Cited by 162
Finck, B. N., & Kelly, D. P. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2061 · Cited by 160
Peroxisome proliferator-activated receptor α protects against alcohol-induced liver damage
Nakajima, T., Kamijo, Y., Tanaka, N., Sugiyama, E., Tanaka, E., Kiyosawa, K., Fukushima, Y., Peters, J. M., Gonzalez, F. J., & Aoyama, T. (2004) · Hepatology · doi:10.1002/hep.1840400428 · Cited by 158
Self-citationIglarz, M., Touyz, R. M., Viel, E. C., Paradis, P., Amiri, F., Diep, Q. N., & Schiffrin, E. L. (2003) · Hypertension · doi:10.1161/01.hyp.0000083511.91817.b1 · Cited by 146
SHIROSHITATAKESHITA, A., BRUNDEL, B., BURSTEIN, B., LEUNG, T., MITAMURA, H., OGAWA, S., & NATTEL, S. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.01.002 · Cited by 149
Maintaining Ancient Organelles: Mitochondrial Biogenesis and Maturation
Vega, R. B., Horton, J. L., & Kelly, D. P. (2015) · Circulation Research · doi:10.1161/circresaha.116.305420 · Cited by 146
Delayed liver regeneration in peroxisome proliferator-activated receptor-α-null mice
Anderson, S. P., Yoon, L., Richard, E. B., Dunn, C. S., Cattley, R. C., & Corton, C. J. (2002) · Hepatology · doi:10.1053/jhep.2002.35276 · Cited by 147
Vallée, A., & Lecarpentier, Y. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00459 · Cited by 141
PPARδ modulates lipopolysaccharide-induced TNFα inflammation signaling in cultured cardiomyocytes
Ding, G., Cheng, L., Qin, Q., Frontin, S., & Yang, Q. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.03.422 · Cited by 153
Lipoxidation in cardiovascular diseases
Gianazza, E., Brioschi, M., Fernandez, A. M., & Banfi, C. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101119 · Cited by 152
Shohet, R. V., & Garcia, J. A. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0279-x · Cited by 149
Lü, B., Jiang, Y. J., Zhou, Y., Xu, F. Y., Hatch, G. M., & Choy, P. C. (2005) · Biochemical Journal · doi:10.1042/bj20041348 · Cited by 146
Murray, A. J., Panagia, M., Hauton, D., Gibbons, G. F., & Clarke, K. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3496 · Cited by 134
Cheng, L., Ding, G., Qin, Q., Xiao, Y., Woods, D., Chen, Y. E., & Yang, Q. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.127 · Cited by 141
Cardiac hypertrophy is enhanced in PPAR -/- mice in response to chronic pressure overload
Smeets, P. J. H., Teunissen, B. E. J., Willemsen, P. H. M., van Nieuwenhoven, F. A., Brouns, A. E., Janssen, B. J. A., Cleutjens, J. P. M., Staels, B., van der Vusse, G. J., & van Bilsen, M. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn001 · Cited by 126
Akiyama, T. E., Nicol, C. J., Fievet, C., Staels, B., Ward, J. M., Auwerx, J., Lee, S. S. T., Gonzalez, F. J., & Peters, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107073200 · Cited by 121
Self-citationOGATA, T., MIYAUCHI, T., SAKAI, S., IRUKAYAMA-TOMOBE, Y., GOTO, K., & YAMAGUCHI, I. (2002) · Clinical Science · doi:10.1042/cs103s284s · Cited by 116
PPARs modulate cardiac metabolism and mitochondrial function in diabetes
Lee, T.-W., Bai, K.-J., Lee, T.-I., Chao, T.-F., Kao, Y.-H., & Chen, Y.-J. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-016-0309-5 · Cited by 110
Listenberger, L. L., & Schaffer, J. E. (2002) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00152-4 · Cited by 123
Glycogen Synthase Kinase-3α Promotes Fatty Acid Uptake and Lipotoxic Cardiomyopathy
Nakamura, M., Liu, T., Husain, S., Zhai, P., Warren, J. S., Hsu, C., Matsuda, T., Phiel, C. J., Cox, J. E., Tian, B., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.005 · Cited by 121
Cardiac Myocyte KLF5 Regulates Ppara Expression and Cardiac Function
Drosatos, K., Pollak, N. M., Pol, C. J., Ntziachristos, P., Willecke, F., Valenti, M.-C., Trent, C. M., Hu, Y., Guo, S., Aifantis, I., et al. (2015) · Circulation Research · doi:10.1161/circresaha.115.306383 · Cited by 119
Histone methyltransferase Smyd1 regulates mitochondrial energetics in the heart
Warren, J. S., Tracy, C. M., Miller, M. R., Makaju, A., Szulik, M. W., Oka, S., Yuzyuk, T. N., Cox, J. E., Kumar, A., Lozier, B. K., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800680115 · Cited by 119
Genomics of the Human Carnitine Acyltransferase Genes
van der Leij, F. R., Huijkman, N., Boomsma, C. M., Kuipers, J. R. G., & Bartelds, B. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3055 · Cited by 116
Cardiac Hypertrophy: Mechanisms and Therapeutic Opportunities
Gupta, S., Das, B., & Sen, S. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1474 · Cited by 115
Updating the effects of fatty acids on skeletal muscle
Silveira, L. R., Fiamoncini, J., Hirabara, S. M., Procópio, J., Cambiaghi, T. D., Pinheiro, C. H. J., Lopes, L. R., & Curi, R. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21514 · Cited by 104
Roles of PPARs on regulating myocardial energy and lipid homeostasis
Yang, Q., & Li, Y. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0170-9 · Cited by 113
Peroxisome proliferator-activated receptors and cardiovascular remodeling
Schiffrin, E. L. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00677.2004 · Cited by 113
PGC1/PPAR drive cardiomyocyte maturation at single cell level via YAP1 and SF3B2
Murphy, S. A., Miyamoto, M., Kervadec, A., Kannan, S., Tampakakis, E., Kambhampati, S., Lin, B. L., Paek, S., Andersen, P., Lee, D.-I., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21957-z · Cited by 103
Deranged Myocardial Fatty Acid Metabolism in Heart Failure
Yamamoto, T., & Sano, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020996 · Cited by 112
Erol, E., Kumar, L. S., Cline, G. W., Shulman, G. I., Kelly, D. P., & Binas, B. (2003) · The FASEB Journal · doi:10.1096/fj.03-0330fje · Cited by 112
Peroxisome proliferator-activated receptor alpha is downregulated in the failing human heart.
Karbowska, J., Kochan, Z., & Smolenski, R. T. (2003) · PubMed · Cited by 110
Mouse models of mitochondrial dysfunction and heart failure
Russell, L. K., Finck, B. N., & Kelly, D. J. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.10.010 · Cited by 109
Corton, J. C., & Brown-Borg, H. M. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.12.1494 · Cited by 106
Lean heart: Role of leptin in cardiac hypertrophy and metabolism
Hall, M. E., Harmancey, R., & Stec, D. E. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i9.511 · Cited by 106
Lee, W.-S., & Kim, J. (2015) · PPAR Research · doi:10.1155/2015/271983 · Cited by 91
Kaimoto, S., Hoshino, A., Ariyoshi, M., Okawa, Y., Tateishi, S., Ono, K., Uchihashi, M., Fukai, K., Iwai-Kanai, E., & Matoba, S. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00553.2016 · Cited by 103
High fat diet induced diabetic cardiomyopathy
Dirkx, E., Schwenk, R. W., Glatz, J. F. C., Luiken, J. J. F. P., & van Eys, G. J. J. M. (2011) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2011.04.018 · Cited by 104
Chen, X., Wang, Q., Shao, M., Ma, L., Guo, D., Wu, Y. L., Gao, P., Wang, X., Li, W., Li, C., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109487 · Cited by 101
Bezafibrate is a dual ligand for PPARα and PPARβ: studies using null mice
Peters, J. M., Aoyama, T., Burns, A., & Gonzalez, F. J. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(03)00065-9 · Cited by 100
Self-citationThe PPARα‐PGC‐1α Axis Controls Cardiac Energy Metabolism in Healthy and Diseased Myocardium
Duncan, J. G., & Finck, B. N. (2007) · PPAR Research · doi:10.1155/2008/253817 · Cited by 101
Duszka, K., Gregor, A., Guillou, H., König, J. S., & Wahli, W. (2020) · Cells · doi:10.3390/cells9071708 · Cited by 90
Less Extrahepatic Induction of Fatty Acid β-Oxidation Enzymes by PPARα
Cook, W. S., Yeldandi, A. V., Rao, M. S., Hashimoto, T., & Reddy, J. K. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3739 · Cited by 90
Malik, V. S., Chiuve, S. E., Campos, H., Rimm, E. B., Mozaffarian, D., Hu, F. B., & Sun, Q. (2015) · Circulation · doi:10.1161/circulationaha.114.014911 · Cited by 89
Metabolomics of the interaction between PPAR‐α and age in the PPAR‐α‐null mouse
Atherton, H. J., Gulston, M. K., Bailey, N. J., Cheng, K., Zhang, W., Clarke, K., & Griffin, J. L. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.18 · Cited by 80
Supruniuk, E., Mikłosz, A., & Chabowski, A. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00923 · Cited by 89
McVicker, B. L., & Bennett, R. G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00318 · Cited by 85
Tabernero, A., Schoonjans, K., Jesel, L., Carpusca, I., Auwerx, J., & Andriantsitohaina, R. (2002) · BMC Pharmacology · doi:10.1186/1471-2210-2-10 · Cited by 77
BARRERO, M. J., CAMARERO, N., MARRERO, P. F., & HARO, D. (2003) · Biochemical Journal · doi:10.1042/bj20020851 · Cited by 72
Panagia, M., Gibbons, G. F., Radda, G. K., & Clarke, K. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00200.2004 · Cited by 84
PPARα Protects Proximal Tubular Cells from Acute Fatty Acid Toxicity
Kamijo, Y., Hora, K., Kono, K., Takahashi, K., Higuchi, M., Ehara, T., Kiyosawa, K., Shigematsu, H., Gonzalez, F. J., & Aoyama, T. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007020238 · Cited by 81
Self-citationPPAR-γ and AMPK – Advantageous targets for myocardial ischemia/reperfusion therapy
Morrison, A., & Li, J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.04.004 · Cited by 79
Cai, Y., Liu, H., Song, E., Wang, L., Xu, J., He, Y., Zhang, D., Zhang, L., Cheng, K. K. Y., Jin, L., et al. (2021) · Theranostics · doi:10.7150/thno.51739 · Cited by 78
Role of oxidative stress in cardiac dysfunction of PPARα−/−mice
Guellich, A., Damy, T., Lecarpentier, Y., Conti, M., Claes, V., Samuel, J.-L., Quillard, J., Hébert, J.-L., Pineau, T., & Coirault, C. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00037.2007 · Cited by 75
Peroxisome proliferator-activated receptors: Lipid binding proteins controling gene expression
van Bilsen, M., Vusse, G. J., Gilde, A. J., Lindhout, M., & van der Lee, K. A. J. M. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1020553428294 · Cited by 77
Cardiac nuclear receptors: architects of mitochondrial structure and function
Vega, R. B., & Kelly, D. P. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88888 · Cited by 76
Autophagy-activating strategies to promote innate defense against mycobacteria
Kim, Y. S., Silwal, P., Kim, S. Y., Yoshimori, T., & Jo, E. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0290-7 · Cited by 77
Hafstad, A. D., Khalid, A. M., Hagve, M., Lund, T., Larsen, T. S., Severson, D. L., Clarke, K., Berge, R. K., & Aasum, E. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp132 · Cited by 66
Guéant, J., Akoum, R. E., Ziegler, O., Coelho, D., Feigerlová, E., Daval, J., & Guéant‐Rodriguez, R. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1339-4 · Cited by 75
Soppa, G. K. R., Smolenski, R. T., Latif, N., Yuen, A. H. Y., Malik, A. H., Karbowska, J., Kochan, Z., Terracciano, C. M., & Yacoub, M. H. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00624.2004 · Cited by 74
Harada, Y., Tanaka, N., Ichikawa, M., Kamijo, Y., Sugiyama, E., Gonzalez, F. J., & Aoyama, T. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1669-z · Cited by 72
Self-citationPeroxisome proliferator-activated receptors: Lipid binding proteins controling gene expression
van Bilsen, M., Vusse, G. J., Gilde, A. J., Lindhout, M., & van der Lee, K. A. J. M. (2002) · Springer eBooks · doi:10.1007/978-1-4419-9270-3_17 · Cited by 72
Identification of Functions of Peroxisome Proliferator-Activated Receptor α in Proximal Tubules
Kamijo, Y., Hora, K., Tanaka, N., Usuda, N., Kiyosawa, K., Nakajima, T., Gonzalez, F. J., & Aoyama, T. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000018403.61042.56 · Cited by 67
Self-citationTransgenesis and cardiac energetics: new insights into cardiac metabolism
Ingwall, J. S. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.020 · Cited by 69
Metadata
- Authors
- Watanabe, K., Fujii, H., Takahashi, T., Kodama, M., Aizawa, Y., Ohta, Y., Ono, T., Hasegawa, G., Naito, M., Nakajima, T., Kamijo, Y., Gonzalez, F. J., & Aoyama, T.
- Affiliations
- Niigata University of Pharmacy and Medical and Life Sciences (JP)
- Niigata University (JP)
- Shinshu University (JP)
- National Institutes of Health (US)
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-07
- Volume
- 275
- Issue
- 29
- Pages
- 22293-22299
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2099834627
- Cited by
- 314
- References
- 43
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 8 · 2023: 7 · 2022: 7 · 2021: 12 · 2020: 8 · 2019: 10 · 2018: 13 · 2017: 16 · 2016: 16 · 2015: 17 · 2014: 12 · 2013: 6 · 2012: 10
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7401 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- PPARα, cardiac fatty acid metabolism, PPARalpha-null mice, fatty acid transporters, peroxisomal beta-oxidation, lignoceric acid, myocardial fibrosis, caveolae, mitochondrial cristae, nuclear receptors
- MeSH terms
- Aging, Animals, Fatty Acids, Myocardium, Nuclear Proteins, Oxidation-Reduction, Transcription Factors, Immunoblotting, Receptors, Cytoplasmic and Nuclear, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.